Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/24/2015 08/25/2015 08/26/2015 08/27/2015 08/28/2015 Date
17.02(c) 17.35(c) 18.01(c) 18.14(c) 18.4 Last
293 577 162 735 207 398 214 106 61 359 Volume
-3.35% +1.94% +3.80% +0.72% +1.43% Change
More quotes
Financials ($)
Sales 2015 97,7 M
EBIT 2015 8,77 M
Net income 2015 7,27 M
Debt 2015 -
Yield 2015 -
Sales 2016 126 M
EBIT 2016 18,0 M
Net income 2016 16,3 M
Debt 2016 -
Yield 2016 -
PER 2015 86,38
PER 2016 39,87
Capi. / Sales 2015 6,39x
Capi. / Sales 2016 4,96x
Capitalization 625 M
More Financials
Company
Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and wound healing markets.The company operates its business through two segments: Therapeutics and Biosurgery segment.The Therapeutics... 
More about the company
Surperformance© ratings of Osiris Therapeutics, Inc.
Trading Rating : - Investor Rating :
More Ratings
Latest news on OSIRIS THERAPEUTICS, INC.
08/13 OSIRIS THERAPEUTICS : Announces Second Quarter 2015 Financial Results
08/10 OSIRIS THERAPEUTICS : Management's Discussion and Analysis of Financial Conditio..
08/05 OSIRIS THERAPEUTICS : posts 2Q profit
08/05 OSIRIS THERAPEUTICS : Results of Operations and Financial Condition, Financial S..
08/05 OSIRIS THERAPEUTICS : Announces Second Quarter 2015 Financial Results
07/14 OSIRIS THERAPEUTICS : Announces Second Quarter 2015 Financial Results Conference..
06/12 OSIRIS THERAPEUTICS : Submission of Matters to a Vote of Security Holders, Other..
05/29 OSIRIS THERAPEUTICS : Updates on Establishment of an International Subsidiary
More news
Sector news : Bio Therapeutic Drugs
08:01a QUINTILES TRANSNATIONAL : CEO to Present at UBS Best of Americas 2015 Conference
08/27 ACTELION : Additional data on selexipag (uptravi) and macitentan (opsumit) to be..
08/27 GENMAB A/S : Data Published in The New England Journal of Medicine Shows Daratum..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
08/06 PREMARKET BIOTECH DIGEST PART 2 : My Top Biopicks 2015 Performance, Anavex Bigge..
08/05 Osiris Therapeutics' (OSIR) CEO Lode Debrabandere on Q2 2015 Results - Earnin..
08/05 Osiris Therapeutics revenues up 78% in Q2
08/05 Osiris Therapeutics (OSIR) Q2 2015 Results - Earnings Call Webcast
08/05 Osiris Therapeutics misses by $0.03, beats on revenue


Comments 
Advertisement
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Technical analysis trends OSIRIS THERAPEUTI...
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions